Healthcare provider profile · identity verified

Madeeha Hafeez, M.D.

Internal Medicine · NORTH WALES, PA · NPI 1568841021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	504	59
Sertraline Hcl	Sertraline Hcl	485	39
Gabapentin	Gabapentin	429	48
Furosemide	Furosemide	387	56
Amlodipine Besylate	Amlodipine Besylate	374	49
Levothyroxine Sodium	Levothyroxine Sodium	343	45
Eliquis	Apixaban	294	38
Trazodone Hcl	Trazodone Hcl	290	24
Pantoprazole Sodium	Pantoprazole Sodium	286	44
Metoprolol Succinate	Metoprolol Succinate	260	34
Mirtazapine	Mirtazapine	259	28
Tamsulosin Hcl	Tamsulosin Hcl	246	25
Famotidine	Famotidine	176	20
Losartan Potassium	Losartan Potassium	175	24
Donepezil Hcl	Donepezil Hcl	167	19
Clopidogrel	Clopidogrel Bisulfate	160	19
Potassium Chloride	Potassium Chloride	145	29
Lisinopril	Lisinopril	144	23
Metoprolol Tartrate	Metoprolol Tartrate	141	16
Omeprazole	Omeprazole	141	21
Carvedilol	Carvedilol	133	14
Rosuvastatin Calcium	Rosuvastatin Calcium	131	17
Venlafaxine Hcl Er	Venlafaxine Hcl	111	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	108	18
Latanoprost	Latanoprost	99	17
Metformin Hcl	Metformin Hcl	95	15
Finasteride	Finasteride	93	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	93	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	81	11
Prednisone	Prednisone	80	12
Carbidopa-Levodopa	Carbidopa/Levodopa	76	suppressed
Amiodarone Hcl	Amiodarone Hcl	75	suppressed
Montelukast Sodium	Montelukast Sodium	74	suppressed
Midodrine Hcl	Midodrine Hcl	68	suppressed
Simvastatin	Simvastatin	68	13
Tramadol Hcl	Tramadol Hcl	66	24
Bupropion Xl	Bupropion Hcl	65	suppressed
Warfarin Sodium	Warfarin Sodium	62	suppressed
Duloxetine Hcl	Duloxetine Hcl	56	11
Divalproex Sodium	Divalproex Sodium	55	suppressed
Fluticasone Propionate	Fluticasone Propionate	54	19
Bumetanide	Bumetanide	53	suppressed
Loperamide	Loperamide Hcl	53	12
Xarelto	Rivaroxaban	52	suppressed
Lorazepam	Lorazepam	46	17
Metolazone	Metolazone	42	suppressed
Metformin Hcl Er	Metformin Hcl	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Aripiprazole	Aripiprazole	39	suppressed
Memantine Hcl Er	Memantine Hcl	39	suppressed
Atenolol	Atenolol	36	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Gemtesa	Vibegron	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Olanzapine	Olanzapine	29	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	27	suppressed
Nystatin	Nystatin	27	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	18
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	suppressed
Oxcarbazepine	Oxcarbazepine	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Digoxin	Digoxin	23	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Trospium Chloride Er	Trospium Chloride	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	13
Enulose	Lactulose	20	suppressed
Torsemide	Torsemide	20	suppressed
Travoprost	Travoprost	20	suppressed
Risperidone	Risperidone	19	suppressed
Nystop	Nystatin	18	11
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Meloxicam	Meloxicam	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Budesonide	Budesonide	12	suppressed
Clonidine	Clonidine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Neupro	Rotigotine	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error